本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

28.13
-0.5200-1.82%
盤後28.500.3700+1.32%17:29 EDT
成交量:281.01萬
成交額:7,960.38萬
市值:35.53億
市盈率:-15.42
高:28.97
開:28.84
低:27.85
收:28.65
52周最高:41.94
52周最低:16.10
股本:1.26億
流通股本:7,811.99萬
量比:1.47
換手率:3.60%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
淨資產收益率:-108.49%
總資產收益率:-13.77%
市淨率:22.73
市盈率(LYR):-17.61

資料載入中...

2023/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

重要事件披露

Form 8-K - Current report
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

SEC問詢函

Form CORRESP - Correspondence
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/01

重要事件披露

Form 8-K - Current report
2023/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities